Benitec Biopharma Inc. Common Stock
Symbol: BNTC (NASDAQ)
13.38
▼ (-4.36%) -0.610
Company Description:
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Key Stats
- Today's Open: $14
- Today's High: $14.01
- Today's Low: $13.38
- Today's Volume: 43.69K
- Yesterday Close: $13.99
- Yesterday High: $14.01
- Yesterday Low: $13.705
- Yesterday Volume: 21.89K
- Last Min Volume: 1
- Last Min High: $13.38
- Last Min Low: $13.38
- Last Min VWAP: $13.38
Company Profile
- Name: Benitec Biopharma Inc. Common Stock
- Website: https://www.benitec.com
- Listed Date: 2012-07-11
- Location: HAYWARD, CA
- Market Status: Active
- CIK Number: 0001808898
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $363.31M
- Round Lot: 100
- Outstanding Shares: 26.25M
- Asset Type: CS
RECENT FILINGS FOR BNTC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-07-09 | 8-K | View |
| 2025-06-02 | EFFECT | View |
| 2025-06-02 | 424B3 | View |
| 2025-05-29 | CORRESP | View |
| 2025-05-29 | UPLOAD | View |
| 2025-05-23 | S-3 | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-14 | SCHEDULE 13G/A | View |
| 2025-05-14 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-09 | SCHEDULE 13G/A | View |
| 2025-04-02 | 4 | View |
| 2025-03-28 | 8-K | View |
| 2025-03-28 | 4 | View |
| 2025-03-28 | SCHEDULE 13D/A | View |
| 2025-03-27 | 8-K | View |
| 2025-03-26 | 424B5 | View |
| 2025-03-26 | 8-K | View |
Latest News on BNTC